Skip to main content
SpringerLink
Log in

Utilizzo del tolvaptan nell’iponatremia secondaria a SIADH

  • Pratica Clinica in Endocrinologia
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Schrier RW, Gross P, Gheorghiade M et al. (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355:2099–2112

    Article  CAS  PubMed  Google Scholar 

  2. Verbalis JG, Goldsmith SR, Greenberg A et al. (2014) Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 126:S1–S42

    Article  Google Scholar 

  3. Spasovski G, Vanholder R, Allolio B et al. (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 170:G1–G47

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrinologia, Dipartimento di Medicina Interna, Università Cattolica, Roma, Italia

    Silvia Della Casa

  2. Unità di Endocrinologia, Dipartimento di Scienze Biomediche Sperimentali e Cliniche “Mario Serio”, Università degli Studi di Firenze, Firenze, Italia

    Alessandro Peri

  3. SC Endocrinologia, AO Ordine Mauriziano, Torino, Italia

    Paola Razzore

Authors
  1. Silvia Della Casa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandro Peri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paola Razzore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro Peri.

Ethics declarations

Conflitto di interesse

Gli autori Silvia Della Casa, Alessandro Peri e Paola Razzore dichiarano di avere ricevuto compensi per consulenze e/o supporto alla ricerca da parte di Otsuka.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Della Casa, S., Peri, A. & Razzore, P. Utilizzo del tolvaptan nell’iponatremia secondaria a SIADH. L'Endocrinologo 17, 207–209 (2016). https://doi.org/10.1007/s40619-016-0226-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-016-0226-6

Search

Navigation